Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC
Clinical trial NCT03222089 · WITHDRAWN
Trial details
- NCT number
- NCT03222089
- Sponsor
- Fujian Cancer Hospital
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-20
- Primary completion
- 2019-07-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.